IL-18BP hFc Chimera, Human

NEW

Item number	Size	Datasheet	Manual	SDS	Delivery time	Quantity	Price
GSC-Z05453-100	100 µg		-		7-10 business days*		228.00€
GSC-Z05453-500	500 µg		-		7-10 business days*		753.00€

If you have any questions, please use our Contact Form.
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk

Cytokines were the first modern immunotherapies to produce durable responses in patients with... more

Close menu

Product information "IL-18BP hFc Chimera, Human"

Cytokines were the first modern immunotherapies to produce durable responses in patients with advanced cancer,components of the interleukin-18 (IL-18) pathway are upregulated on tumour-infiltrating lymphocytes, suggesting that IL-18 therapy could enhance anti-tumour immunity. IL-18BP, a high-affinity IL-18 decoy receptor, is frequently upregulated in diverse human and mouse tumours and limits the anti-tumour activity of IL-18 in mice.

Keywords:	IL18BP, Tadekinig-alfa, Interleukin-18-binding protein
Supplier:	GenScript
Supplier-Nr:	Z05453

Properties

Conjugate:	No
Species reactivity:	human
MW:	44.4 kD
Purity:	>95% (Bis-Tris PAGE)

Database Information

KEGG ID :	K25565 \| Matching products
UniProt ID :	O95998 \| Matching products
Gene ID :	GeneID 10068 \| Matching products

Handling & Safety

Storage:	-20°C
Shipping:	+4°C (International: °C)

Caution
Our products are for laboratory research use only: Not for administration to humans!

Information about the product reference will follow. more

Close menu

You will get a certificate here

Go back

Read, write and discuss reviews... more

Close menu

Customer review for "IL-18BP hFc Chimera, Human"

Write a review